clinical trial · NCT05992922
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
Dry Eye SyndromesIC265 Ophthalmic Solution 1%Placebo Ophthalmic Solution (Vehicle)
brief summary
This study will evaluate the safety, tolerability and efficacy of IC265 compared to vehicle in participants with signs and symptoms dry eye disease.
started
Oct 17, 2023
primary completion
Dec 19, 2023
completion
Dec 19, 2023
last updated
Apr 25, 2025
official title
A Phase 2, Single-Center, Randomized, Double- Masked, Placebo-Controlled Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution 1% in Subjects Diagnosed With Dry Eye Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol